動物の血液と成分世界市場の見通し：詳細分析、予測(～2031年)

当レポートは、動物の血液と成分 (Animal Blood & Components) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

• 概要 動物の血液と成分: 定義、特性、主要属性
• 市場セグメント：タイプ別
  • 世界の動物の血液と成分 市場規模：タイプ別, 2020 VS 2024 VS 2031
  • Bovine
  • Canine
  • Feline
  • Sheep
  • Equine
  • Camelid
  • Others
• 市場セグメント：アプリケーション別
  • 世界の動物の血液と成分 市場規模：用途別, 2020 VS 2024 VS 2031
  • Medical Research
  • Scientific Research
  • Industrial Applications
  • Other
• 前提条件と制限
• 調査目的
• 対象期間

第2章 レポート概要

• 世界の動物の血液と成分の収益 推定および予測 2020-2031
• 世界の動物の血液と成分 収益：地域別
  • 収益比較: 2020 VS 2024 VS 2031
  • 収益実績と予測 地域別 (2020--2031)
  • 世界の収益市場シェア 地域別 (2020-2031)
• 世界の動物の血液と成分 売上予測・予想 2020-2031
• 世界の動物の血液と成分 販売：地域別
  • 売上比較: 2020 VS 2024 VS 2031
  • 販売実績と予測 地域別 (2020-2031)
  • 新興市場: 成長要因と投資動向
  • 世界の販売市場シェア 地域別 (2020-2031)

第3章 競合：企業別

• 世界の動物の血液と成分 販売：企業別
  • 世界の販売数量 ：企業別 (2020-2025)
  • 世界のトップ5とトップ10企業の市場シェア：販売数量別 (2024)
• 世界の動物の血液と成分 企業収益ランキングとTier
  • 世界の収益 (価格) ：企業別 (2020-2025)
  • 世界の主要企業収益ランキング (2023 vs. 2024)
  • 収益ベースのTierセグメンテーション (Tier 1, Tier 2, and Tier 3)
• 企業の収益性プロファイルと価格戦略
  • 総利益率 ：トップ企業別 (2020 VS 2024)
  • メーカー希望小売価格動向 (2020-2025)
• 主要企業 製造拠点、本社
• 主要製品タイプ 市場規模 ：企業別
  • Bovine Market Size by Manufacturers
  • Canine Market Size by Manufacturers
  • Feline Market Size by Manufacturers
  • Sheep Market Size by Manufacturers
  • Equine Market Size by Manufacturers
  • Camelid Market Size by Manufacturers
  • Others Market Size by Manufacturers
• 世界の動物の血液と成分 市場集中と力学
  • 世界の市場集中 (CR5 and HHI)
  • 新規参入／イグジットの影響分析
  • 戦略的な動き: 合併と買収、能力拡大、研究開発投資

第4章 世界の製品セグメンテーション分析

• 世界の動物の血液と成分 販売実績 タイプ別
  • 世界の販売実績と予測 タイプ別 (2020-2031)
  • 世界の販売市場シェア：タイプ別 (2020-2031)
• 世界の動物の血液と成分 収益動向 タイプ別
  • 世界の収益実績と予測 タイプ別 (2020-2031)
  • 世界の収益市場シェア：タイプ別 (2020-2031)
• 世界の平均 販売価格 (ASP) 動向 タイプ別 (2020-2031)
• 製品技術の差別化
• サブタイプの力学: 成長リーダー、収益性、リスク
  • 高成長な特定分野と採用ドライバー
  • 収益ホットスポットとコストドライバー
  • 代替品の脅威

第5章 世界の下流アプリケーション分析

• 世界の動物の血液と成分 販売：用途別
  • 世界の販売実績と予測 用途別 (2020-2031)
  • 世界の販売市場シェア：用途別 (2020-2031)
  • 高成長アプリケーション識別
  • 新興アプリケーションのケーススタディ
• 世界の動物の血液と成分 収益：用途別
  • 世界の実績al andの収益予測：用途別 (2020-2031)
  • の収益市場シェア：用途別 (2020-2031)
• 世界の価格力学 用途別 (2020-2031)
• 下流 顧客分析
  • トップ顧客 地域別
  • トップ顧客 用途別

第6章 北米

• 北米の販売数量と収益 (2020-2031)
• 北米の主要企業 売上 収益 2024年
• 北米の動物の血液と成分 売上高と収益：タイプ別 (2020-2031)
• 北米の動物の血液と成分 売上高と収益：アプリケーション別 (2020-2031)
• 北米の成長促進要因と市場障壁
• 北米の動物の血液と成分 市場規模：国別
  • 北米の収益：国別
  • 北米の販売動向 国別
  • US
  • カナダ
  • メキシコ

第7章 欧州

• 欧州の販売数量と収益 (2020-2031)
• 欧州の主要企業 売上 収益 2024年
• 欧州の動物の血液と成分 売上高と収益：タイプ別 (2020-2031)
• 欧州の動物の血液と成分 売上高と収益：アプリケーション別 (2020-2031)
• 欧州の成長促進要因と市場障壁
• 欧州の動物の血液と成分 市場規模：国別
  • 欧州の収益：国別
  • 欧州の販売動向 国別
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア

第8章 アジア太平洋地域

• アジア太平洋地域 販売数量と収益 (2020-2031)
• アジア太平洋地域 主要企業 売上 収益 2024年
• アジア太平洋地域 動物の血液と成分 売上高と収益：タイプ別 (2020-2031)
• アジア太平洋地域 動物の血液と成分 売上高と収益：アプリケーション別 (2020-2031)
• アジア太平洋地域 動物の血液と成分 市場規模：地域別
  • アジア太平洋地域 収益：地域別
  • アジア太平洋地域 販売動向 地域別
• アジア太平洋地域 成長促進要因と市場障壁
• 東南アジア
  • 東南アジアの収益：国別 (2020 VS 2024 VS 2031)
  • 主要国の分析: インドネシア, ベトナム, タイ, マレーシア, フィリピン
• 中国
• 日本
• 韓国
• 台湾
• インド

第9章 中南米

• 中南米 販売数量と収益 (2020-2031)
• 中南米 主要企業 売上 収益 2024年
• 中南米 動物の血液と成分 売上高と収益：タイプ別 (2020-2031)
• 中南米 動物の血液と成分 売上高と収益：アプリケーション別 (2020-2031)
• 中南米 投資機会と主な課題
• 中南米 動物の血液と成分 市場規模：国別
  • 中南米 収益動向：国別 (2020 VS 2024 VS 2031)
  • ブラジル
  • アルゼンチン

第10章 中東・アフリカ

• 中東・アフリカの販売数量と収益 (2020-2031)
• 中東・アフリカの主要企業 売上 収益 2024年
• 中東・アフリカの動物の血液と成分 売上高と収益：タイプ別 (2020-2031)
• 中東・アフリカの動物の血液と成分 売上高と収益：アプリケーション別 (2020-2031)
• 中東・アフリカの投資機会と主な課題
• 中東・アフリカの動物の血液と成分 市場規模：国別
  • 中東・アフリカの収益動向：国別 (2020 VS 2024 VS 2031)
  • 湾岸協力理事会諸国
  • トルコ
  • エジプト
  • 南アフリカ

第11章 企業プロファイル

• Thermo Fisher Scientific
• Moregate BioTech
• GeminiBio
• Tissue Culture Biologicals
• Bovogen Biologicals (ANZCO Foods Healthcare)
• Biowest(BioNordic A/S)
• Internegocios
• RMBIO
• Biological Industries
• Pel-Freez, LLC
• Cytiva
• HemoStat Laboratories
• CellSera Australia
• Auckland BioSciences
• Animal Technologies
• Serana Europe
• Peak Serum
• Kraeber & Co. GmbH
• Lake Immunogenics
• Agro-Bio
• Bio Nutrientes Do Brasil Ltda.
• Lanzhou Minhai
• Zhejiang Tianhang Biotechnology Co., Ltd.
• Guangzhou Ruite Biotechnology Co., Ltd.
• Obio Technology (Shanghai) Corp., Ltd.
• MoreCare. Inc.

第12章 バリューチェーンとサプライチェーン分析

• 動物の血液と成分 産業チェーン
• 動物の血液と成分 上流材料分析
  • 原材料
  • 主要サプライヤー市場シェアとリスク評価
• 動物の血液と成分 一貫生産分析
  • 製造拠点分析
  • 地域生産市場シェア (2020-2031)
  • 規制および貿易政策の生産への影響
  • 生産技術概要
  • 地域コストの促進要因
• 動物の血液と成分 販売チャネルと流通ネットワーク
  • 販売チャネル
  • 卸業者

第13章 動物の血液と成分 市場動向

• 業界動向と進化
• 市場 成長ドライバーと新興の機会
• 市場の課題、リスク、抑制

第14章 主な調査結果 世界の動物の血液と成分の主な市場調査結果

第15章 付録

List of Tables

Table 1. Global Animal Blood & Components Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Animal Blood & Components Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Animal Blood & Components Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Animal Blood & Components Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Animal Blood & Components Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Animal Blood & Components Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (KL)

Table 7. Global Animal Blood & Components Sales by Region (2020-2025) & (KL)

Table 8. Global Animal Blood & Components Sales by Region (2026-2031) & (KL)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Animal Blood & Components Sales by Manufacturers (2020-2025) & (KL)

Table 11. Global Animal Blood & Components Sales Share by Manufacturers (2020-2025)

Table 12. Global Animal Blood & Components Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Animal Blood & Components Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers'Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Animal Blood & Components by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Blood & Components as of 2024)

Table 16. Global Animal Blood & Components Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Animal Blood & Components Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/L)

Table 18. Key Manufacturers Animal Blood & Components Manufacturing Base and Headquarters

Table 19. Global Animal Blood & Components Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) - Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Animal Blood & Components Sales by Type (2020-2025) & (KL)

Table 23. Global Animal Blood & Components Sales by Type (2026-2031) & (KL)

Table 24. Global Animal Blood & Components Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Animal Blood & Components Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Animal Blood & Components ASP by Type (2020-2031) & (US$/L)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Animal Blood & Components Sales by Application (2020-2025) & (KL)

Table 29. Global Animal Blood & Components Sales by Application (2026-2031) & (KL)

Table 30. Animal Blood & Components High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Animal Blood & Components Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Animal Blood & Components Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Animal Blood & Components ASP by Application (2020-2031) & (US$/L)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Animal Blood & Components Growth Accelerators and Market Barriers

Table 37. North America Animal Blood & Components Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Animal Blood & Components Sales (KL) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Animal Blood & Components Growth Accelerators and Market Barriers

Table 40. Europe Animal Blood & Components Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Animal Blood & Components Sales (KL) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Animal Blood & Components Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Animal Blood & Components Sales (KL) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Animal Blood & Components Growth Accelerators and Market Barriers

Table 45. Southeast Asia Animal Blood & Components Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Animal Blood & Components Investment Opportunities and Key Challenges

Table 47. Central and South America Animal Blood & Components Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Animal Blood & Components Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Animal Blood & Components Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Thermo Fisher Scientific Corporation Information

Table 51. Thermo Fisher Scientific Description and Major Businesses

Table 52. Thermo Fisher Scientific Product Models, Descriptions and Specifications

Table 53. Thermo Fisher Scientific Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 54. Thermo Fisher Scientific Sales Value Proportion by Product in 2024

Table 55. Thermo Fisher Scientific Sales Value Proportion by Application in 2024

Table 56. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024

Table 57. Thermo Fisher Scientific Animal Blood & Components SWOT Analysis

Table 58. Thermo Fisher Scientific Recent Developments

Table 59. Moregate BioTech Corporation Information

Table 60. Moregate BioTech Description and Major Businesses

Table 61. Moregate BioTech Product Models, Descriptions and Specifications

Table 62. Moregate BioTech Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 63. Moregate BioTech Sales Value Proportion by Product in 2024

Table 64. Moregate BioTech Sales Value Proportion by Application in 2024

Table 65. Moregate BioTech Sales Value Proportion by Geographic Area in 2024

Table 66. Moregate BioTech Animal Blood & Components SWOT Analysis

Table 67. Moregate BioTech Recent Developments

Table 68. GeminiBio Corporation Information

Table 69. GeminiBio Description and Major Businesses

Table 70. GeminiBio Product Models, Descriptions and Specifications

Table 71. GeminiBio Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 72. GeminiBio Sales Value Proportion by Product in 2024

Table 73. GeminiBio Sales Value Proportion by Application in 2024

Table 74. GeminiBio Sales Value Proportion by Geographic Area in 2024

Table 75. GeminiBio Animal Blood & Components SWOT Analysis

Table 76. GeminiBio Recent Developments

Table 77. Tissue Culture Biologicals Corporation Information

Table 78. Tissue Culture Biologicals Description and Major Businesses

Table 79. Tissue Culture Biologicals Product Models, Descriptions and Specifications

Table 80. Tissue Culture Biologicals Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 81. Tissue Culture Biologicals Sales Value Proportion by Product in 2024

Table 82. Tissue Culture Biologicals Sales Value Proportion by Application in 2024

Table 83. Tissue Culture Biologicals Sales Value Proportion by Geographic Area in 2024

Table 84. Tissue Culture Biologicals Animal Blood & Components SWOT Analysis

Table 85. Tissue Culture Biologicals Recent Developments

Table 86. Bovogen Biologicals (ANZCO Foods Healthcare) Corporation Information

Table 87. Bovogen Biologicals (ANZCO Foods Healthcare) Description and Major Businesses

Table 88. Bovogen Biologicals (ANZCO Foods Healthcare) Product Models, Descriptions and Specifications

Table 89. Bovogen Biologicals (ANZCO Foods Healthcare) Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 90. Bovogen Biologicals (ANZCO Foods Healthcare) Sales Value Proportion by Product in 2024

Table 91. Bovogen Biologicals (ANZCO Foods Healthcare) Sales Value Proportion by Application in 2024

Table 92. Bovogen Biologicals (ANZCO Foods Healthcare) Sales Value Proportion by Geographic Area in 2024

Table 93. Bovogen Biologicals (ANZCO Foods Healthcare) Animal Blood & Components SWOT Analysis

Table 94. Bovogen Biologicals (ANZCO Foods Healthcare) Recent Developments

Table 95. Biowest(BioNordic A/S) Corporation Information

Table 96. Biowest(BioNordic A/S) Description and Major Businesses

Table 97. Biowest(BioNordic A/S) Product Models, Descriptions and Specifications

Table 98. Biowest(BioNordic A/S) Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 99. Biowest(BioNordic A/S) Recent Developments

Table 100. Internegocios Corporation Information

Table 101. Internegocios Description and Major Businesses

Table 102. Internegocios Product Models, Descriptions and Specifications

Table 103. Internegocios Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 104. Internegocios Recent Developments

Table 105. RMBIO Corporation Information

Table 106. RMBIO Description and Major Businesses

Table 107. RMBIO Product Models, Descriptions and Specifications

Table 108. RMBIO Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 109. RMBIO Recent Developments

Table 110. Biological Industries Corporation Information

Table 111. Biological Industries Description and Major Businesses

Table 112. Biological Industries Product Models, Descriptions and Specifications

Table 113. Biological Industries Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 114. Biological Industries Recent Developments

Table 115. Pel-Freez, LLC Corporation Information

Table 116. Pel-Freez, LLC Description and Major Businesses

Table 117. Pel-Freez, LLC Product Models, Descriptions and Specifications

Table 118. Pel-Freez, LLC Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 119. Pel-Freez, LLC Recent Developments

Table 120. Cytiva Corporation Information

Table 121. Cytiva Description and Major Businesses

Table 122. Cytiva Product Models, Descriptions and Specifications

Table 123. Cytiva Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 124. Cytiva Recent Developments

Table 125. HemoStat Laboratories Corporation Information

Table 126. HemoStat Laboratories Description and Major Businesses

Table 127. HemoStat Laboratories Product Models, Descriptions and Specifications

Table 128. HemoStat Laboratories Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 129. HemoStat Laboratories Recent Developments

Table 130. CellSera Australia Corporation Information

Table 131. CellSera Australia Description and Major Businesses

Table 132. CellSera Australia Product Models, Descriptions and Specifications

Table 133. CellSera Australia Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 134. CellSera Australia Recent Developments

Table 135. Auckland BioSciences Corporation Information

Table 136. Auckland BioSciences Description and Major Businesses

Table 137. Auckland BioSciences Product Models, Descriptions and Specifications

Table 138. Auckland BioSciences Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 139. Auckland BioSciences Recent Developments

Table 140. Animal Technologies Corporation Information

Table 141. Animal Technologies Description and Major Businesses

Table 142. Animal Technologies Product Models, Descriptions and Specifications

Table 143. Animal Technologies Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 144. Animal Technologies Recent Developments

Table 145. Serana Europe Corporation Information

Table 146. Serana Europe Description and Major Businesses

Table 147. Serana Europe Product Models, Descriptions and Specifications

Table 148. Serana Europe Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 149. Serana Europe Recent Developments

Table 150. Peak Serum Corporation Information

Table 151. Peak Serum Description and Major Businesses

Table 152. Peak Serum Product Models, Descriptions and Specifications

Table 153. Peak Serum Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 154. Peak Serum Recent Developments

Table 155. Kraeber & Co. GmbH Corporation Information

Table 156. Kraeber & Co. GmbH Description and Major Businesses

Table 157. Kraeber & Co. GmbH Product Models, Descriptions and Specifications

Table 158. Kraeber & Co. GmbH Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 159. Kraeber & Co. GmbH Recent Developments

Table 160. Lake Immunogenics Corporation Information

Table 161. Lake Immunogenics Description and Major Businesses

Table 162. Lake Immunogenics Product Models, Descriptions and Specifications

Table 163. Lake Immunogenics Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 164. Lake Immunogenics Recent Developments

Table 165. Agro-Bio Corporation Information

Table 166. Agro-Bio Description and Major Businesses

Table 167. Agro-Bio Product Models, Descriptions and Specifications

Table 168. Agro-Bio Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 169. Agro-Bio Recent Developments

Table 170. Bio Nutrientes Do Brasil Ltda. Corporation Information

Table 171. Bio Nutrientes Do Brasil Ltda. Description and Major Businesses

Table 172. Bio Nutrientes Do Brasil Ltda. Product Models, Descriptions and Specifications

Table 173. Bio Nutrientes Do Brasil Ltda. Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 174. Bio Nutrientes Do Brasil Ltda. Recent Developments

Table 175. Lanzhou Minhai Corporation Information

Table 176. Lanzhou Minhai Description and Major Businesses

Table 177. Lanzhou Minhai Product Models, Descriptions and Specifications

Table 178. Lanzhou Minhai Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 179. Lanzhou Minhai Recent Developments

Table 180. Zhejiang Tianhang Biotechnology Co., Ltd. Corporation Information

Table 181. Zhejiang Tianhang Biotechnology Co., Ltd. Description and Major Businesses

Table 182. Zhejiang Tianhang Biotechnology Co., Ltd. Product Models, Descriptions and Specifications

Table 183. Zhejiang Tianhang Biotechnology Co., Ltd. Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 184. Zhejiang Tianhang Biotechnology Co., Ltd. Recent Developments

Table 185. Guangzhou Ruite Biotechnology Co., Ltd. Corporation Information

Table 186. Guangzhou Ruite Biotechnology Co., Ltd. Description and Major Businesses

Table 187. Guangzhou Ruite Biotechnology Co., Ltd. Product Models, Descriptions and Specifications

Table 188. Guangzhou Ruite Biotechnology Co., Ltd. Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 189. Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments

Table 190. Obio Technology (Shanghai) Corp., Ltd. Corporation Information

Table 191. Obio Technology (Shanghai) Corp., Ltd. Description and Major Businesses

Table 192. Obio Technology (Shanghai) Corp., Ltd. Product Models, Descriptions and Specifications

Table 193. Obio Technology (Shanghai) Corp., Ltd. Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 194. Obio Technology (Shanghai) Corp., Ltd. Recent Developments

Table 195. MoreCare. Inc. Corporation Information

Table 196. MoreCare. Inc. Description and Major Businesses

Table 197. MoreCare. Inc. Product Models, Descriptions and Specifications

Table 198. MoreCare. Inc. Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 199. MoreCare. Inc. Recent Developments

Table 200. Key Raw Materials Distribution

Table 201. Raw Materials Key Suppliers

Table 202. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 203. Milestones in Production Technology Evolution

Table 204. Distributors List

Table 205. Market Trends and Market Evolution

Table 206. Market Drivers and Opportunities

Table 207. Market Challenges, Risks, and Restraints

Table 208. Research Programs/Design for This Report

Table 209. Key Data Information from Secondary Sources

Table 210. Key Data Information from Primary Sources

List of Figures

Figure 1. Animal Blood & Components Product Picture

Figure 2. Global Animal Blood & Components Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Bovine Product Picture

Figure 4. Canine Product Picture

Figure 5. Feline Product Picture

Figure 6. Sheep Product Picture

Figure 7. Equine Product Picture

Figure 8. Camelid Product Picture

Figure 9. Others Product Picture

Figure 10. Global Animal Blood & Components Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 11. Medical Research

Figure 12. Scientific Research

Figure 13. Industrial Applications

Figure 14. Other

Figure 15. Animal Blood & Components Report Years Considered

Figure 16. Global Animal Blood & Components Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 18. Global Animal Blood & Components Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 19. Global Animal Blood & Components Revenue Market Share by Region (2020-2031)

Figure 20. Global Animal Blood & Components Sales (2020-2031) & (KL)

Figure 21. Global Animal Blood & Components Sales (CAGR) by Region (2020-2031) (KL)

Figure 22. Global Animal Blood & Components Sales Market Share by Region (2020-2031)

Figure 23. Top 5 and Top 10 Manufacturers Animal Blood & Components Sales Volume Market Share in 2024

Figure 24. Global Animal Blood & Components Revenue Market Share Ranking (2024)

Figure 25. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 26. Bovine Revenue Market Share by Manufacturer in 2024

Figure 27. Canine Revenue Market Share by Manufacturer in 2024

Figure 28. Feline Revenue Market Share by Manufacturer in 2024

Figure 29. Sheep Revenue Market Share by Manufacturer in 2024

Figure 30. Equine Revenue Market Share by Manufacturer in 2024

Figure 31. Camelid Revenue Market Share by Manufacturer in 2024

Figure 32. Others Revenue Market Share by Manufacturer in 2024

Figure 33. Global Animal Blood & Components Sales Market Share by Type (2020-2031)

Figure 34. Global Animal Blood & Components Revenue Market Share by Type (2020-2031)

Figure 35. Global Animal Blood & Components Sales Market Share by Application (2020-2031)

Figure 36. Global Animal Blood & Components Revenue Market Share by Application (2020-2031)

Figure 37. North America Animal Blood & Components Sales YoY (2020-2031) & (KL)

Figure 38. North America Animal Blood & Components Revenue YoY (2020-2031) & (US$ Million)

Figure 39. North America Top 5 Manufacturers Animal Blood & Components Sales Revenue (US$ Million) in 2024

Figure 40. North America Animal Blood & Components Sales Volume (KL) by Type (2020- 2031)

Figure 41. North America Animal Blood & Components Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 42. North America Animal Blood & Components Sales Volume (KL) by Application (2020-2031)

Figure 43. North America Animal Blood & Components Sales Revenue (US$ Million) by Application (2020-2031)

Figure 44. US Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 45. Canada Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 46. Mexico Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 47. Europe Animal Blood & Components Sales YoY (2020-2031) & (KL)

Figure 48. Europe Animal Blood & Components Revenue YoY (2020-2031) & (US$ Million)

Figure 49. Europe Top 5 Manufacturers Animal Blood & Components Sales Revenue (US$ Million) in 2024

Figure 50. Europe Animal Blood & Components Sales Volume (KL) by Type (2020-2031)

Figure 51. Europe Animal Blood & Components Sales Revenue (US$ Million) by Type (2020-2031)

Figure 52. Europe Animal Blood & Components Sales Volume (KL) by Application (2020-2031)

Figure 53. Europe Animal Blood & Components Sales Revenue (US$ Million) by Application (2020-2031)

Figure 54. Germany Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 55. France Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 56. U.K. Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 57. Italy Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 58. Russia Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 59. Asia-Pacific Animal Blood & Components Sales YoY (2020-2031) & (KL)

Figure 60. Asia-Pacific Animal Blood & Components Revenue YoY (2020-2031) & (US$ Million)

Figure 61. Asia-Pacific Top 8 Manufacturers Animal Blood & Components Sales Revenue (US$ Million) in 2024

Figure 62. Asia-Pacific Animal Blood & Components Sales Volume (KL) by Type (2020- 2031)

Figure 63. Asia-Pacific Animal Blood & Components Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 64. Asia-Pacific Animal Blood & Components Sales Volume (KL) by Application (2020-2031)

Figure 65. Asia-Pacific Animal Blood & Components Sales Revenue (US$ Million) by Application (2020-2031)

Figure 66. Indonesia Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 67. Japan Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 68. South Korea Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 69. China Taiwan Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 70. India Animal Blood & Components Revenue (2020-2031) & (US$ Million)

Figure 71. Central and South America Animal Blood & Components Sales YoY (2020-2031) & (KL)

Figure 72. Central and South America Animal Blood & Components Revenue YoY (2020-2031) & (US$ Million)

Figure 73. Central and South America Top 5 Manufacturers Animal Blood & Components Sales Revenue (US$ Million) in 2024

Figure 74. Central and South America Animal Blood & Components Sales Volume (KL) by Type (2021-2031)

Figure 75. Central and South America Animal Blood & Components Sales Revenue (US$ Million) by Type (2020-2031)

Figure 76. Central and South America Animal Blood & Components Sales Volume (KL) by Application (2020-2031)

Figure 77. Central and South America Animal Blood & Components Sales Revenue (US$ Million) by Application (2020-2031)

Figure 78. Brazil Animal Blood & Components Revenue (2020-2025) & (US$ Million)

Figure 79. Argentina Animal Blood & Components Revenue (2020-2025) & (US$ Million)

Figure 80. Middle East, and Africa Animal Blood & Components Sales YoY (2020-2031) & (KL)

Figure 81. Middle East and Africa Animal Blood & Components Revenue YoY (2020-2031) & (US$ Million)

Figure 82. Middle East and Africa Top 5 Manufacturers Animal Blood & Components Sales Revenue (US$ Million) in 2024

Figure 83. Middle East and Africa Animal Blood & Components Sales Volume (KL) by Type (2021-2031)

Figure 84. South America Animal Blood & Components Sales Revenue (US$ Million) by Type (2020-2031)

Figure 85. Middle East and Africa Animal Blood & Components Sales Volume (KL) by Application (2020-2031)

Figure 86. Middle East and Africa Animal Blood & Components Sales Revenue (US$ Million) by Application (2020-2031)

Figure 87. GCC Countries Animal Blood & Components Revenue (2020-2025) & (US$ Million)

Figure 88. Turkey Animal Blood & Components Revenue (2020-2025) & (US$ Million)

Figure 89. Egypt Animal Blood & Components Revenue (2020-2025) & (US$ Million)

Figure 90. South Africa Animal Blood & Components Revenue (2020-2025) & (US$ Million)

Figure 91. Animal Blood & Components Industry Chain Mapping

Figure 92. Regional Animal Blood & Components Manufacturing Base Distribution (%)

Figure 93. Global Animal Blood & Components Production Market Share by Region (2020-2031)

Figure 94. Animal Blood & Components Production Process

Figure 95. Regional Animal Blood & Components Production Cost Structure

Figure 96. Channels of Distribution (Direct Vs Distribution)

Figure 97. Bottom-up and Top-down Approaches for This Report

Figure 98. Data Triangulation

Figure 99. Key Executives Interviewed

This research report focuses on the Animal Blood & Components Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Introduction to Animal Blood & Components: Definition, Properties, and Key Attributes
• 1.2 Market Segmentation by Type
  • 1.2.1 Global Animal Blood & Components Market Size by Type, 2020 VS 2024 VS 2031
  • 1.2.2 Bovine
  • 1.2.3 Canine
  • 1.2.4 Feline
  • 1.2.5 Sheep
  • 1.2.6 Equine
  • 1.2.7 Camelid
  • 1.2.8 Others
• 1.3 Market Segmentation by Application
  • 1.3.1 Global Animal Blood & Components Market Size by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Medical Research
  • 1.3.3 Scientific Research
  • 1.3.4 Industrial Applications
  • 1.3.5 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Animal Blood & Components Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Animal Blood & Components Revenue by Region
  • 2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
  • 2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
  • 2.2.3 Global Revenue Market Share by Region (2020-2031)
• 2.3 Global Animal Blood & Components Sales Estimates and Forecasts 2020-2031
• 2.4 Global Animal Blood & Components Sales by Region
  • 2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
  • 2.4.2 Historical and Forecasted Sales by Region (2020-2031)
  • 2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
  • 2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

• 3.1 Global Animal Blood & Components Sales by Manufacturers
  • 3.1.1 Global Sales Volume by Manufacturers (2020-2025)
  • 3.1.2 Global Top 5 and Top 10 Manufacturers'Market Share by Sales Volume (2024)
• 3.2 Global Animal Blood & Components Manufacturer Revenue Rankings and Tiers
  • 3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
  • 3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
  • 3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
• 3.3 Manufacturer Profitability Profiles and Pricing Strategies
  • 3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
  • 3.3.2 Manufacturer-Level Price Trends (2020-2025)
• 3.4 Key Manufacturers Manufacturing Base and Headquarters
• 3.5 Main Product Type Market Size by Manufacturers
  • 3.5.1 Bovine Market Size by Manufacturers
  • 3.5.2 Canine Market Size by Manufacturers
  • 3.5.3 Feline Market Size by Manufacturers
  • 3.5.4 Sheep Market Size by Manufacturers
  • 3.5.5 Equine Market Size by Manufacturers
  • 3.5.6 Camelid Market Size by Manufacturers
  • 3.5.7 Others Market Size by Manufacturers
• 3.6 Global Animal Blood & Components Market Concentration and Dynamics
  • 3.6.1 Global Market Concentration (CR5 and HHI)
  • 3.6.2 Entrant/Exit Impact Analysis
  • 3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

• 4.1 Global Animal Blood & Components Sales Performance by Type
  • 4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
  • 4.1.2 Global Sales Market Share by Type (2020-2031)
• 4.2 Global Animal Blood & Components Revenue Trends by Type
  • 4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
  • 4.2.2 Global Revenue Market Share by Type (2020-2031)
• 4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
• 4.4 Product Technology Differentiation
• 4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
  • 4.5.1 High-Growth Niches and Adoption Drivers
  • 4.5.2 Profitability Hotspots and Cost Drivers
  • 4.5.3 Substitution Threats

5 Global Downstream Application Analysis

• 5.1 Global Animal Blood & Components Sales by Application
  • 5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
  • 5.1.2 Global Sales Market Share by Application (2020-2031)
  • 5.1.3 High-Growth Application Identification
  • 5.1.4 Emerging Application Case Studies
• 5.2 Global Animal Blood & Components Revenue by Application
  • 5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
  • 5.2.2 Revenue Market Share by Application (2020-2031)
• 5.3 Global Pricing Dynamics by Application (2020-2031)
• 5.4 Downstream Customer Analysis
  • 5.4.1 Top Customers by Region
  • 5.4.2 Top Customers by Application

6 North America

• 6.1 North America Sales Volume and Revenue (2020-2031)
• 6.2 North America Key Manufacturers Sales Revenue in 2024
• 6.3 North America Animal Blood & Components Sales and Revenue by Type (2020-2031)
• 6.4 North America Animal Blood & Components Sales and Revenue by Application (2020-2031)
• 6.5 North America Growth Accelerators and Market Barriers
• 6.6 North America Animal Blood & Components Market Size by Country
  • 6.6.1 North America Revenue by Country
  • 6.6.2 North America Sales Trends by Country
  • 6.6.3 US
  • 6.6.4 Canada
  • 6.6.5 Mexico

7 Europe

• 7.1 Europe Sales Volume and Revenue (2020-2031)
• 7.2 Europe Key Manufacturers Sales Revenue in 2024
• 7.3 Europe Animal Blood & Components Sales and Revenue by Type (2020-2031)
• 7.4 Europe Animal Blood & Components Sales and Revenue by Application (2020-2031)
• 7.5 Europe Growth Accelerators and Market Barriers
• 7.6 Europe Animal Blood & Components Market Size by Country
  • 7.6.1 Europe Revenue by Country
  • 7.6.2 Europe Sales Trends by Country
  • 7.6.3 Germany
  • 7.6.4 France
  • 7.6.5 U.K.
  • 7.6.6 Italy
  • 7.6.7 Russia

8 Asia-Pacific

• 8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
• 8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
• 8.3 Asia-Pacific Animal Blood & Components Sales and Revenue by Type (2020-2031)
• 8.4 Asia-Pacific Animal Blood & Components Sales and Revenue by Application (2020-2031)
• 8.5 Asia-Pacific Animal Blood & Components Market Size by Region
  • 8.5.1 Asia-Pacific Revenue by Region
  • 8.5.2 Asia-Pacific Sales Trends by Region
• 8.6 Asia-Pacific Growth Accelerators and Market Barriers
• 8.7 Southeast Asia
  • 8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
  • 8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
• 8.8 China
• 8.9 Japan
• 8.10 South Korea
• 8.11 China Taiwan
• 8.12 India

9 Central and South America

• 9.1 Central and South America Sales Volume and Revenue (2020-2031)
• 9.2 Central and South America Key Manufacturers Sales Revenue in 2024
• 9.3 Central and South America Animal Blood & Components Sales and Revenue by Type (2020-2031)
• 9.4 Central and South America Animal Blood & Components Sales and Revenue by Application (2020-2031)
• 9.5 Central and South America Investment Opportunities and Key Challenges
• 9.6 Central and South America Animal Blood & Components Market Size by Country
  • 9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
  • 9.6.2 Brazil
  • 9.6.3 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
• 10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
• 10.3 Middle East and Africa Animal Blood & Components Sales and Revenue by Type (2020-2031)
• 10.4 Middle East and Africa Animal Blood & Components Sales and Revenue by Application (2020-2031)
• 10.5 Middle East and Africa Investment Opportunities and Key Challenges
• 10.6 Middle East and Africa Animal Blood & Components Market Size by Country
  • 10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
  • 10.6.2 GCC Countries
  • 10.6.3 Turkey
  • 10.6.4 Egypt
  • 10.6.5 South Africa

11 Corporate Profile

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Thermo Fisher Scientific Corporation Information
  • 11.1.2 Thermo Fisher Scientific Business Overview
  • 11.1.3 Thermo Fisher Scientific Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.1.4 Thermo Fisher Scientific Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.5 Thermo Fisher Scientific Animal Blood & Components Sales by Product in 2024
  • 11.1.6 Thermo Fisher Scientific Animal Blood & Components Sales by Application in 2024
  • 11.1.7 Thermo Fisher Scientific Animal Blood & Components Sales by Geographic Area in 2024
  • 11.1.8 Thermo Fisher Scientific Animal Blood & Components SWOT Analysis
  • 11.1.9 Thermo Fisher Scientific Recent Developments
• 11.2 Moregate BioTech
  • 11.2.1 Moregate BioTech Corporation Information
  • 11.2.2 Moregate BioTech Business Overview
  • 11.2.3 Moregate BioTech Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.2.4 Moregate BioTech Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.5 Moregate BioTech Animal Blood & Components Sales by Product in 2024
  • 11.2.6 Moregate BioTech Animal Blood & Components Sales by Application in 2024
  • 11.2.7 Moregate BioTech Animal Blood & Components Sales by Geographic Area in 2024
  • 11.2.8 Moregate BioTech Animal Blood & Components SWOT Analysis
  • 11.2.9 Moregate BioTech Recent Developments
• 11.3 GeminiBio
  • 11.3.1 GeminiBio Corporation Information
  • 11.3.2 GeminiBio Business Overview
  • 11.3.3 GeminiBio Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.3.4 GeminiBio Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.5 GeminiBio Animal Blood & Components Sales by Product in 2024
  • 11.3.6 GeminiBio Animal Blood & Components Sales by Application in 2024
  • 11.3.7 GeminiBio Animal Blood & Components Sales by Geographic Area in 2024
  • 11.3.8 GeminiBio Animal Blood & Components SWOT Analysis
  • 11.3.9 GeminiBio Recent Developments
• 11.4 Tissue Culture Biologicals
  • 11.4.1 Tissue Culture Biologicals Corporation Information
  • 11.4.2 Tissue Culture Biologicals Business Overview
  • 11.4.3 Tissue Culture Biologicals Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.4.4 Tissue Culture Biologicals Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.4.5 Tissue Culture Biologicals Animal Blood & Components Sales by Product in 2024
  • 11.4.6 Tissue Culture Biologicals Animal Blood & Components Sales by Application in 2024
  • 11.4.7 Tissue Culture Biologicals Animal Blood & Components Sales by Geographic Area in 2024
  • 11.4.8 Tissue Culture Biologicals Animal Blood & Components SWOT Analysis
  • 11.4.9 Tissue Culture Biologicals Recent Developments
• 11.5 Bovogen Biologicals (ANZCO Foods Healthcare)
  • 11.5.1 Bovogen Biologicals (ANZCO Foods Healthcare) Corporation Information
  • 11.5.2 Bovogen Biologicals (ANZCO Foods Healthcare) Business Overview
  • 11.5.3 Bovogen Biologicals (ANZCO Foods Healthcare) Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.5.4 Bovogen Biologicals (ANZCO Foods Healthcare) Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.5.5 Bovogen Biologicals (ANZCO Foods Healthcare) Animal Blood & Components Sales by Product in 2024
  • 11.5.6 Bovogen Biologicals (ANZCO Foods Healthcare) Animal Blood & Components Sales by Application in 2024
  • 11.5.7 Bovogen Biologicals (ANZCO Foods Healthcare) Animal Blood & Components Sales by Geographic Area in 2024
  • 11.5.8 Bovogen Biologicals (ANZCO Foods Healthcare) Animal Blood & Components SWOT Analysis
  • 11.5.9 Bovogen Biologicals (ANZCO Foods Healthcare) Recent Developments
• 11.6 Biowest(BioNordic A/S)
  • 11.6.1 Biowest(BioNordic A/S) Corporation Information
  • 11.6.2 Biowest(BioNordic A/S) Business Overview
  • 11.6.3 Biowest(BioNordic A/S) Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.6.4 Biowest(BioNordic A/S) Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.6.5 Biowest(BioNordic A/S) Recent Developments
• 11.7 Internegocios
  • 11.7.1 Internegocios Corporation Information
  • 11.7.2 Internegocios Business Overview
  • 11.7.3 Internegocios Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.7.4 Internegocios Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.7.5 Internegocios Recent Developments
• 11.8 RMBIO
  • 11.8.1 RMBIO Corporation Information
  • 11.8.2 RMBIO Business Overview
  • 11.8.3 RMBIO Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.8.4 RMBIO Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.8.5 RMBIO Recent Developments
• 11.9 Biological Industries
  • 11.9.1 Biological Industries Corporation Information
  • 11.9.2 Biological Industries Business Overview
  • 11.9.3 Biological Industries Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.9.4 Biological Industries Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.9.5 Biological Industries Recent Developments
• 11.10 Pel-Freez, LLC
  • 11.10.1 Pel-Freez, LLC Corporation Information
  • 11.10.2 Pel-Freez, LLC Business Overview
  • 11.10.3 Pel-Freez, LLC Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.10.4 Pel-Freez, LLC Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.10.5 Pel-Freez, LLC Recent Developments
• 11.11 Cytiva
  • 11.11.1 Cytiva Corporation Information
  • 11.11.2 Cytiva Business Overview
  • 11.11.3 Cytiva Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.11.4 Cytiva Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.11.5 Cytiva Recent Developments
• 11.12 HemoStat Laboratories
  • 11.12.1 HemoStat Laboratories Corporation Information
  • 11.12.2 HemoStat Laboratories Business Overview
  • 11.12.3 HemoStat Laboratories Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.12.4 HemoStat Laboratories Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.12.5 HemoStat Laboratories Recent Developments
• 11.13 CellSera Australia
  • 11.13.1 CellSera Australia Corporation Information
  • 11.13.2 CellSera Australia Business Overview
  • 11.13.3 CellSera Australia Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.13.4 CellSera Australia Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.13.5 CellSera Australia Recent Developments
• 11.14 Auckland BioSciences
  • 11.14.1 Auckland BioSciences Corporation Information
  • 11.14.2 Auckland BioSciences Business Overview
  • 11.14.3 Auckland BioSciences Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.14.4 Auckland BioSciences Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.14.5 Auckland BioSciences Recent Developments
• 11.15 Animal Technologies
  • 11.15.1 Animal Technologies Corporation Information
  • 11.15.2 Animal Technologies Business Overview
  • 11.15.3 Animal Technologies Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.15.4 Animal Technologies Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.15.5 Animal Technologies Recent Developments
• 11.16 Serana Europe
  • 11.16.1 Serana Europe Corporation Information
  • 11.16.2 Serana Europe Business Overview
  • 11.16.3 Serana Europe Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.16.4 Serana Europe Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.16.5 Serana Europe Recent Developments
• 11.17 Peak Serum
  • 11.17.1 Peak Serum Corporation Information
  • 11.17.2 Peak Serum Business Overview
  • 11.17.3 Peak Serum Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.17.4 Peak Serum Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.17.5 Peak Serum Recent Developments
• 11.18 Kraeber & Co. GmbH
  • 11.18.1 Kraeber & Co. GmbH Corporation Information
  • 11.18.2 Kraeber & Co. GmbH Business Overview
  • 11.18.3 Kraeber & Co. GmbH Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.18.4 Kraeber & Co. GmbH Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.18.5 Kraeber & Co. GmbH Recent Developments
• 11.19 Lake Immunogenics
  • 11.19.1 Lake Immunogenics Corporation Information
  • 11.19.2 Lake Immunogenics Business Overview
  • 11.19.3 Lake Immunogenics Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.19.4 Lake Immunogenics Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.19.5 Lake Immunogenics Recent Developments
• 11.20 Agro-Bio
  • 11.20.1 Agro-Bio Corporation Information
  • 11.20.2 Agro-Bio Business Overview
  • 11.20.3 Agro-Bio Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.20.4 Agro-Bio Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.20.5 Agro-Bio Recent Developments
• 11.21 Bio Nutrientes Do Brasil Ltda.
  • 11.21.1 Bio Nutrientes Do Brasil Ltda. Corporation Information
  • 11.21.2 Bio Nutrientes Do Brasil Ltda. Business Overview
  • 11.21.3 Bio Nutrientes Do Brasil Ltda. Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.21.4 Bio Nutrientes Do Brasil Ltda. Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.21.5 Bio Nutrientes Do Brasil Ltda. Recent Developments
• 11.22 Lanzhou Minhai
  • 11.22.1 Lanzhou Minhai Corporation Information
  • 11.22.2 Lanzhou Minhai Business Overview
  • 11.22.3 Lanzhou Minhai Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.22.4 Lanzhou Minhai Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.22.5 Lanzhou Minhai Recent Developments
• 11.23 Zhejiang Tianhang Biotechnology Co., Ltd.
  • 11.23.1 Zhejiang Tianhang Biotechnology Co., Ltd. Corporation Information
  • 11.23.2 Zhejiang Tianhang Biotechnology Co., Ltd. Business Overview
  • 11.23.3 Zhejiang Tianhang Biotechnology Co., Ltd. Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.23.4 Zhejiang Tianhang Biotechnology Co., Ltd. Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.23.5 Zhejiang Tianhang Biotechnology Co., Ltd. Recent Developments
• 11.24 Guangzhou Ruite Biotechnology Co., Ltd.
  • 11.24.1 Guangzhou Ruite Biotechnology Co., Ltd. Corporation Information
  • 11.24.2 Guangzhou Ruite Biotechnology Co., Ltd. Business Overview
  • 11.24.3 Guangzhou Ruite Biotechnology Co., Ltd. Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.24.4 Guangzhou Ruite Biotechnology Co., Ltd. Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.24.5 Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments
• 11.25 Obio Technology (Shanghai) Corp., Ltd.
  • 11.25.1 Obio Technology (Shanghai) Corp., Ltd. Corporation Information
  • 11.25.2 Obio Technology (Shanghai) Corp., Ltd. Business Overview
  • 11.25.3 Obio Technology (Shanghai) Corp., Ltd. Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.25.4 Obio Technology (Shanghai) Corp., Ltd. Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.25.5 Obio Technology (Shanghai) Corp., Ltd. Recent Developments
• 11.26 MoreCare. Inc.
  • 11.26.1 MoreCare. Inc. Corporation Information
  • 11.26.2 MoreCare. Inc. Business Overview
  • 11.26.3 MoreCare. Inc. Animal Blood & Components Product Models, Descriptions and Specifications
  • 11.26.4 MoreCare. Inc. Animal Blood & Components Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.26.5 MoreCare. Inc. Recent Developments

12 Value Chain and Supply-Chain Analysis

• 12.1 Animal Blood & Components Industry Chain
• 12.2 Animal Blood & Components Upstream Materials Analysis
  • 12.2.1 Raw Materials
  • 12.2.2 Key Suppliers Market Share & Risk Assessment
• 12.3 Animal Blood & Components Integrated Production Analysis
  • 12.3.1 Manufacturing Footprint Analysis
  • 12.3.2 Regional Production Market Share (2020-2031)
  • 12.3.3 Regulatory and Trade Policy Impact on Production
  • 12.3.4 Production Technology Overview
  • 12.3.5 Regional Cost Drivers
• 12.4 Animal Blood & Components Sales Channels and Distribution Networks
  • 12.4.1 Sales Channels
  • 12.4.2 Distributors

13 Animal Blood & Components Market Dynamics

• 13.1 Industry Trends and Evolution
• 13.2 Market Growth Drivers and Emerging Opportunities
• 13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Animal Blood & Components Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details